Stage-directed individualized therapy in esophageal cancer
- PMID: 27384385
- DOI: 10.1111/nyas.13113
Stage-directed individualized therapy in esophageal cancer
Abstract
Esophageal cancer is the eighth most common cancer worldwide, and the incidence of esophageal carcinoma is rapidly increasing. With the advent of new staging and treatment techniques, esophageal cancer can now be managed through various strategies. A good understanding of the advances and limitations of new staging techniques and how these can guide in individualizing treatment is important to improve outcomes for esophageal cancer patients. This paper outlines the recent progress in staging and treatment of esophageal cancer, with particularly attention to endoscopic techniques for early-stage esophageal cancer, multimodality treatment for locally advanced esophageal cancer, assessment of response to neoadjuvant treatment, and the role of cervical lymph node dissection. Furthermore, advances in robot-assisted surgical techniques and postoperative recovery protocols that may further improve outcomes after esophagectomy are discussed.
Keywords: anastomotic leakage; esophageal cancer; esophageal surgery; neoadjuvant chemoradiation; robot-assisted; tumor staging.
© 2016 The Authors. Annals of the New York Academy of Sciences published by Wiley Periodicals Inc. on behalf of The New York Academy of Sciences.
Similar articles
-
Personalizing therapy for esophageal cancer patients.Thorac Surg Clin. 2013 Nov;23(4):471-8. doi: 10.1016/j.thorsurg.2013.07.001. Thorac Surg Clin. 2013. PMID: 24199697 Review.
-
Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.Radiat Oncol. 2015 Mar 6;10:59. doi: 10.1186/s13014-015-0361-4. Radiat Oncol. 2015. PMID: 25884226 Free PMC article.
-
Multimodality therapy for esophageal cancer.Oncology (Williston Park). 2010 Nov 15;24(12):1134-8. Oncology (Williston Park). 2010. PMID: 21141694 Review.
-
Chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer patients: is it time for additional evidence?World J Surg Oncol. 2011 Apr 19;9:41. doi: 10.1186/1477-7819-9-41. World J Surg Oncol. 2011. PMID: 21504620 Free PMC article.
-
Treatment of locally advanced esophageal cancer with surgery and chemoradiation.Curr Opin Gastroenterol. 2008 Jul;24(4):535-40. doi: 10.1097/MOG.0b013e3283025ca2. Curr Opin Gastroenterol. 2008. PMID: 18622172 Review.
Cited by
-
An artificial neural network-based radiomics model for predicting the radiotherapy response of advanced esophageal squamous cell carcinoma patients: a multicenter study.Sci Rep. 2023 May 29;13(1):8673. doi: 10.1038/s41598-023-35556-z. Sci Rep. 2023. PMID: 37248363 Free PMC article.
-
Combination of histoculture drug response assay and qPCR as an effective method to screen biomarkers for personalized chemotherapy in esophageal cancer.Oncol Lett. 2017 Dec;14(6):6915-6922. doi: 10.3892/ol.2017.7069. Epub 2017 Sep 26. Oncol Lett. 2017. PMID: 29163710 Free PMC article.
-
Integrin α5 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells.Am J Cancer Res. 2019 Dec 1;9(12):2774-2788. eCollection 2019. Am J Cancer Res. 2019. PMID: 31911861 Free PMC article.
-
MIR548P and TRAV39 Are Potential Indicators of Tumor Microenvironment and Novel Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma.J Oncol. 2022 Sep 17;2022:3152114. doi: 10.1155/2022/3152114. eCollection 2022. J Oncol. 2022. PMID: 36164348 Free PMC article.
-
Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis.Sci Rep. 2020 Oct 29;10(1):18589. doi: 10.1038/s41598-020-75541-4. Sci Rep. 2020. PMID: 33122682 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical